Cytek Biosciences, Inc. Quarterly Selling and Marketing Expense in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Cytek Biosciences, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q2 2020 to Q2 2024.
  • Cytek Biosciences, Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $12.3M, a 14.6% decline year-over-year.
  • Cytek Biosciences, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $48.4M, a 11.8% increase year-over-year.
  • Cytek Biosciences, Inc. annual Selling and Marketing Expense for 2023 was $49.1M, a 47.9% increase from 2022.
  • Cytek Biosciences, Inc. annual Selling and Marketing Expense for 2022 was $33.2M, a 34.5% increase from 2021.
  • Cytek Biosciences, Inc. annual Selling and Marketing Expense for 2021 was $24.7M, a 64.9% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $48.4M $12.3M -$2.1M -14.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $50.5M $12.5M +$1.4M +12.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $49.1M $11.6M +$2.53M +28% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $46.6M $12.1M +$3.27M +37.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $43.4M $14.4M +$5.94M +70.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $37.4M $11.1M +$4.19M +60.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $33.2M $9.03M +$725K +8.73% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $32.5M $8.81M +$2.26M +34.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $30.2M $8.43M +$2.86M +51.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $27.4M $6.96M +$2.68M +62.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $24.7M $8.3M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-13
Q3 2021 $6.55M +$2.72M +70.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $5.58M +$2.52M +82.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $4.28M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $3.84M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $3.06M Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.